Cargando…

Peptide TFP5/TP5 derived from Cdk5 activator P35 provides neuroprotection in the MPTP model of Parkinson’s disease

Parkinson’s disease (PD) is a chronic neurodegenerative disorder characterized by the loss of dopamine neurons in the substantia nigra, decreased striatal dopamine levels, and consequent extrapyramidal motor dysfunction. Recent evidence indicates that cyclin-dependent kinase 5 (Cdk5) is inappropriat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Binukumar, BK., Shukla, Varsha, Amin, Niranjana D., Grant, Philip, Bhaskar, M., Skuntz, Susan, Steiner, Joseph, Pant, Harish C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The American Society for Cell Biology 2015
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4666141/ https://www.ncbi.nlm.nih.gov/pubmed/26399293 http://dx.doi.org/10.1091/mbc.E15-06-0415

Ejemplares similares

TFP5/TP5 peptide provides neuroprotection in the MPTP model of Parkinson's disease
por: Binukumar, BK, et al.
Publicado: (2016)

The interaction of Munc 18 (p67) with the p10 domain of p35 protects in vivo Cdk5/p35 activity from inhibition by TFP5, a peptide derived from p35
por: Amin, Niranjana D., et al.
Publicado: (2016)

Analysis of the Inhibitory Elements in the p5 Peptide Fragment of the CDK5 Activator, p35, CDKR1 Protein
por: Binukumar, B.K., et al.
Publicado: (2015)

TFP5 peptide, derived from CDK5-activating cofactor p35, provides neuroprotection in early-stage of adult ischemic stroke
por: Ji, Ya-Bin, et al.
Publicado: (2017)

TP5: A Novel Therapeutic Approach Targeting Aberrant and Hyperactive CDK5/p25 for the Treatment of Colorectal Carcinoma
por: Amin, Niranjana, et al.
Publicado: (2023)

Therapeutic effects of TP5, a Cdk5/p25 inhibitor, in in vitro and in vivo models of Parkinson’s disease
por: Tran, Judith, et al.
Publicado: (2021)

Knockdown of Expression of Cdk5 or p35 (a Cdk5 Activator) Results in Podocyte Apoptosis
por: Zheng, Ya-Li, et al.
Publicado: (2016)

TP5, a Peptide Inhibitor of Aberrant and Hyperactive CDK5/p25: A Novel Therapeutic Approach against Glioblastoma
por: Tabouret, Emeline, et al.
Publicado: (2020)

Cdk5 Inhibitory Peptide (CIP) Inhibits Cdk5/p25 Activity Induced by High Glucose in Pancreatic Beta Cells and Recovers Insulin Secretion from p25 Damage
por: Zheng, Ya-Li, et al.
Publicado: (2013)

TFP5-Mediated CDK5 Activity Inhibition Improves Diabetic Nephropathy via NGF/Sirt1 Regulating Axis
por: Cao, Shi-Lu, et al.
Publicado: (2022)

Achaete-scute homologue-1 (ASH1) stimulates migration of lung cancer cells through Cdk5/p35 pathway
por: Demelash, Abeba, et al.
Publicado: (2012)

Cyclin-Dependent Kinase 5 Regulates cPLA2 Activity and Neuroinflammation in Parkinson’s Disease
por: Paul, Sangita, et al.
Publicado: (2022)

Searching for Novel Cdk5 Substrates in Brain by Comparative Phosphoproteomics of Wild Type and Cdk5(−/−) Mice
por: Contreras-Vallejos, Erick, et al.
Publicado: (2014)

mPTP opening caused by Cdk5 loss is due to increased mitochondrial Ca(2+) uptake
por: NavaneethaKrishnan, Saranya, et al.
Publicado: (2020)

TFP5 prevents 1-methyl-4-phenyl pyridine ion-induced neurotoxicity in mouse cortical neurons
por: Zhang, Qi-Shan, et al.
Publicado: (2016)

Mesenchymal Stem Cells Loaded with p5, Derived from CDK5 Activator p35, Inhibit Calcium-Induced CDK5 Activation in Endothelial Cells
por: Fang, Wen-Hui, et al.
Publicado: (2016)

Effects of p35 Mutations Associated with Mental Retardation on the Cellular Function of p35-CDK5
por: Takada, Shunsuke, et al.
Publicado: (2015)

Peripheral and orofacial pain sensation is unaffected by the loss of p39
por: Prochazkova, Michaela, et al.
Publicado: (2017)

Activation of cyclin-dependent kinase 5 mediates orofacial mechanical hyperalgesia
por: Prochazkova, Michaela, et al.
Publicado: (2013)

Resveratrol inhibits Cdk5 activity through regulation of p35 expression
por: Utreras, Elias, et al.
Publicado: (2011)

Repositioning of the antipsychotic drug TFP for sepsis treatment
por: Park, Jung Hwa, et al.
Publicado: (2019)

Cdk5/p35 functions as a crucial regulator of spatial learning and memory
por: Mishiba, Tomohide, et al.
Publicado: (2014)

Cdk5 Inhibitory Peptide Prevents Loss of Dopaminergic Neurons and Alleviates Behavioral Changes in an MPTP Induced Parkinson’s Disease Mouse Model
por: He, Rongni, et al.
Publicado: (2018)

Phosphorylation of p27(Kip1) at Thr187 by Cyclin-dependent Kinase 5 Modulates Neural Stem Cell Differentiation
por: Zheng, Ya-Li, et al.
Publicado: (2010)

Altered expression of the Cdk5 activator-like protein, Cdk5α, causes neurodegeneration, in part by accelerating the rate of aging
por: Spurrier, Joshua, et al.
Publicado: (2018)

Biological functions of CDK5 and potential CDK5 targeted clinical treatments
por: Shupp, Alison, et al.
Publicado: (2017)

Neuroprotective effects of 3,5-di-o-caffeoylquinic acid in vitro and in vivo
por: Han, Junkyu, et al.
Publicado: (2011)

Does the Digital Economy Increase Green TFP in Cities?
por: Zhao, Chuanyu, et al.
Publicado: (2023)

Abnormal Mitochondria in a Non-human Primate Model of MPTP-induced Parkinson's Disease: Drp1 and CDK5/p25 Signaling
por: Park, Junghyung, et al.
Publicado: (2019)

Targeting p35/Cdk5 Signalling via CIP-Peptide Promotes Angiogenesis in Hypoxia
por: Bosutti, Alessandra, et al.
Publicado: (2013)

Involvement of Cdk5 activating subunit p35 in synaptic plasticity in excitatory and inhibitory neurons
por: Takahashi, Miyuki, et al.
Publicado: (2022)

3,5-Dimethylpyrazolium 3,5-dinitrosalicylate
por: Wei, Shuaishuai, et al.
Publicado: (2012)

Phosphorylation of the Transient Receptor Potential Ankyrin 1 by Cyclin-dependent Kinase 5 affects Chemo-nociception
por: Hall, Bradford E., et al.
Publicado: (2018)

Vps35 Deficiency Impairs Cdk5/p35 Degradation and Promotes the Hyperphosphorylation of Tau Protein in Retinal Ganglion Cells
por: Gao, Ling, et al.
Publicado: (2020)

Cdk5 protects huntingtin
por: LeBrasseur, Nicole
Publicado: (2005)

Three decades of Cdk5
por: Pao, Ping-Chieh, et al.
Publicado: (2021)

TFP Bioeconomy Impact post Covid-19 on the agricultural economy
por: Zuniga-Gonzalez, C. A.
Publicado: (2023)

Absence of the Cdk5 activator p35 causes adult-onset neurodegeneration in the central brain of Drosophila
por: Trunova, Svetlana, et al.
Publicado: (2012)

CDK5 and Its Activator P35 in Normal Pituitary and in Pituitary Adenomas: Relationship to VEGF Expression
por: Xie, Weiyan, et al.
Publicado: (2014)

Geophysik, 3.5
por: Rawer, Karl
Publicado: (1976)

Cannot write session to /tmp/vufind_sessions/sess_dkhqhkajtmoqs20jso15m8iln5